Maria Alexandra Ribeiro

ORCID: 0000-0003-1947-0523
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Ion channel regulation and function
  • Neuroscience and Neuropharmacology Research
  • Biomedical Ethics and Regulation
  • Health Systems, Economic Evaluations, Quality of Life
  • Childhood Cancer Survivors' Quality of Life
  • Ethics in Clinical Research
  • Photoreceptor and optogenetics research
  • Child and Adolescent Health
  • Pharmaceutical studies and practices
  • Genomics and Rare Diseases
  • Advanced NMR Techniques and Applications
  • Memory and Neural Mechanisms
  • International Development and Aid
  • Receptor Mechanisms and Signaling
  • Molecular spectroscopy and chirality
  • Respiratory Support and Mechanisms
  • Artificial Intelligence in Healthcare and Education
  • Cardiac electrophysiology and arrhythmias
  • Neuroscience and Neural Engineering
  • Adolescent and Pediatric Healthcare

Universidade Nova de Lisboa
1991-2023

University of Lisbon
2023

Nova Medical (United States)
1992

Abstract Ethical review systems need to build on their experiences of COVID-19 research enhance preparedness for future pandemics. Recommendations from representatives over twenty countries include: improving relationships across the ecosystem; demonstrating willingness reform and adapt processes; making case robustly better resourcing.

10.1186/s12910-023-00957-2 article EN cc-by BMC Medical Ethics 2023-10-27

Abstract Background The COVID-19 pandemic has had a devastating impact on multiple aspects of healthcare, but also triggered new ways working, stimulated novel approaches in clinical research and reinforced the value previous innovations. Conect4children (c4c, www.conect4children.org ) is large collaborative European network to facilitate development medicines for paediatric populations, made up 35 academic 10 industry partners from 20 countries, more than 50 third parties, around 500...

10.1038/s41390-021-01587-3 article EN cc-by Pediatric Research 2021-06-07

Advice from multiple stakeholders is required to design the optimal pediatric clinical trial. We present recommendations for acquiring advice trial experts and patients/caregivers, derived meetings that were performed through a collaboration of Collaborative Network European Clinical Trials Children (c4c) Patient-CEntric ClinicAl TRial PLatforms (EU-PEARL). Three performed: (1) an meeting methodology experts, (2) (3) combined with both patients/caregivers. Trial recruited c4c database....

10.1111/cts.13547 article EN cc-by-nc Clinical and Translational Science 2023-06-30

The postnatal evolution of the signals underlying afterhyperpolarization (slow-AHP and medium-AHP) was studied in rat CA1 hippocampal neurones (P10-16, P17-23 P greater than 26) using vitro slices. Noradrenaline (NA) signal subtraction were used to decompose AHP (m-AHP s-AHP). amplitude s-AHP found significant between P10-16 cells; m-AHP showed no change. time peak 26 cells be significantly different from remaining groups; changes waveform at this stage mainly due modifications slow-AHP.

10.1097/00001756-199207000-00002 article EN Neuroreport 1992-07-01

<h3>Background</h3> The Biomedical Ethics and Regulatory Capacity Building for Portuguese Speaking African Countries Project (BERC-Luso) was a four-year initiative that aimed to enhance biomedical ethics regulatory capacities in Angola, Cape-Verde, Guinea Bissau, Mozambique, São Tomé Príncipe, Portugal. project established network of National Committees (NCEs), Authorities (NRAs), experts research, developed comparative legislative study, created educational programs promote capacity...

10.1136/bmjgh-2023-edc.33 article EN 2023-12-01

BERC-Luso is a project for building Ethics and Regulatory Capacity, to be developed in four sub-Saharan African countries: Angola, Guinea-Bissau, Mozambique Cape Verde, implemented 2018–2021. National Committees (NECs) Authorities (NRAs) have been engaged (6 institutions) with the partnership of 4 Portuguese institutions (experts ethical review regulatory supervision). Considering that: 1) clinical trials are fundamental improve healthcare develop biomedical research; but 2) can only take...

10.1136/bmjgh-2019-edc.132 article EN cc-by-nc-nd BMJ Global Health 2019-04-01

Objective: to identify the main innovative aspects of Regulation on clinical trials medicines for human use, in terms opportunities research and development reflect ethical challenges this new legal framework. Methods: documentary, descriptive, comparative study regard with Directive 2001/20/EC, reading bibliography published PubMed, using combined or simple such as clinical, trials, European, Regulation, Directive, opportunities, innovation. Results: identified were Portal submission trial...

10.17566/ciads.v10i3.775 article EN cc-by CADERNOS IBERO-AMERICANOS DE DIREITO SANITÁRIO 2021-09-16
Coming Soon ...